Methods and Compositions for the Activation of Gamma-Delta T-Cells
Country:
US
Docket No:
436313-003137
Publication Number:
11,534,450
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued December 27, 2022.
Sequence Agnostic – Methods only
Methods of activating GD T Cells through treatment with bisphosphonate drug and inhibition of FDPS; Methods of activating lymphocytes through treatment with bisphosphonate drug and inhibition of enzyme of mevalonate pathway.
